Contact US | Chinese
You Position: Home > Journal issue
Drug Evaluation Drug Evaluation

2023:

2022:

2021:

2020:

2019:

2018:

2017:

2016:

2015:

2014:

2013:

2012:

2011:

2010:

2009:

2008:

2007:

2006:

2005:

2004:

Drug Evaluation

Items 1-5 of 15
«Preious | of 3 |
1

Actuality Usage of Sulfonylureas on Type 2 Diabetes at Home and Abroad

Drug Evaluation, Volume 14, Issue 3,2017, Pages 7-11, doi:10.3969/j.issn.1672-2809.2017.03.002

2

Cardiovascular Safety of Sulfonylureas in Type 2 Diabetes Mellitus

Drug Evaluation, Volume 14, Issue 3,2017, Pages 36-39, doi:10.3969/j.issn.1672-2809.2017.03.009

3

Risks and Management of Hypoglycemia Caused by Sulfonylureas

Drug Evaluation, Volume 14, Issue 3,2017, Pages 28-31, doi:10.3969/j.issn.1672-2809.2017.03.007

4

How to Evaluate the Secondary Sulfonylureaa Failure

Drug Evaluation, Volume 14, Issue 3,2017, Pages 40-44, doi:10.3969/j.issn.1672-2809.2017.03.010

5

Objectively Evaluating The Situation and Rational Administration of Sulfonylureas

Drug Evaluation, Volume 14, Issue 3,2017, Pages 5-6, doi:10.3969/j.issn.1672-2809.2017.03.001

Items 1-5 of 15
«Preious | of 3 |
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn